• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.

作者信息

Phipps C, Lupo-Stanghellini M T, Flowers M E D

机构信息

1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Department of Haematology, Singapore General Hospital, Singapore, Singapore.

1] Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA, USA [2] Hematology and Bone Marrow Transplantation Unit, San Raffaele Scientific Institute, Milan, Italy.

出版信息

Bone Marrow Transplant. 2014 Feb;49(2):315-6. doi: 10.1038/bmt.2013.159. Epub 2013 Sep 30.

DOI:10.1038/bmt.2013.159
PMID:24076547
Abstract
摘要

相似文献

1
Treatment of refractory sclerodermatous chronic graft-versus-host disease with intravenous lidocaine infusions.静脉输注利多卡因治疗难治性硬皮病样慢性移植物抗宿主病
Bone Marrow Transplant. 2014 Feb;49(2):315-6. doi: 10.1038/bmt.2013.159. Epub 2013 Sep 30.
2
Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft-versus-host disease.芦可替尼治疗难治性硬皮病慢性移植物抗宿主病的疗效与耐受性
Br J Dermatol. 2017 Nov;177(5):e206-e208. doi: 10.1111/bjd.15593. Epub 2017 Oct 22.
3
Sclerodermatous Chronic Graft-versus-Host Disease Treated With Imatinib: A Dermatological Perspective.伊马替尼治疗硬皮病样慢性移植物抗宿主病：皮肤病学视角
Actas Dermosifiliogr (Engl Ed). 2018 Apr;109(3):241-247. doi: 10.1016/j.ad.2017.11.003. Epub 2017 Dec 15.
4
Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.静脉注射利多卡因对供体淋巴细胞输注继发的皮肤慢性移植物抗宿主病的有益作用。
Bone Marrow Transplant. 2001 Jul;28(1):97-9. doi: 10.1038/sj.bmt.1703080.
5
Lack of efficacy of rituximab in refractory sclerodermatous chronic GVHD.
Bone Marrow Transplant. 2012 May;47(5):737-8. doi: 10.1038/bmt.2011.150. Epub 2011 Jul 25.
6
Imatinib: A New Tool for the Management of Chronic Sclerodermatous Graft-Vs-Host Disease.伊马替尼：治疗慢性硬皮病型移植物抗宿主病的新工具。
Actas Dermosifiliogr (Engl Ed). 2018 Apr;109(3):200-201. doi: 10.1016/j.ad.2017.12.002. Epub 2018 Feb 21.
7
FTY720 ameliorates murine sclerodermatous chronic graft-versus-host disease by promoting expansion of splenic regulatory cells and inhibiting immune cell infiltration into skin.FTY720通过促进脾脏调节性细胞的扩增并抑制免疫细胞浸润皮肤来改善小鼠硬皮病样慢性移植物抗宿主病。
Arthritis Rheum. 2013 Jun;65(6):1624-35. doi: 10.1002/art.37933.
8
[Sclerodermatous cutaneous reaction of graft vs host disease treated with thalidomide].[用沙利度胺治疗移植物抗宿主病的硬皮病样皮肤反应]
Presse Med. 1993;22(1):37.
9
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.甲磺酸伊马替尼在激素难治性硬皮病样慢性移植物抗宿主病中的疗效和耐受性有限。
Blood. 2012 Dec 13;120(25):5089-90. doi: 10.1182/blood-2012-09-453928.
10
Sclerodermatous chronic graft-versus-host disease--a report of four pediatric cases.硬皮病样慢性移植物抗宿主病——4例儿科病例报告
Pediatr Dermatol. 2008 Mar-Apr;25(2):240-4. doi: 10.1111/j.1525-1470.2008.00643.x.

引用本文的文献

1
New water-soluble palladium(II) complexes of lidocaine and phenylcyanamide derivative ligands: cytotoxicity and cellular response mechanisms.利多卡因和苯氰胺衍生物配体的新型水溶性钯（II）配合物：细胞毒性和细胞反应机制
Invest New Drugs. 2016 Dec;34(6):723-732. doi: 10.1007/s10637-016-0393-0. Epub 2016 Sep 19.

本文引用的文献

1
Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease.慢性移植物抗宿主病患者硬化的发生率、风险因素和结局。
Blood. 2013 Jun 20;121(25):5098-103. doi: 10.1182/blood-2012-10-464198. Epub 2013 Apr 1.
2
Limited efficacy and tolerance of imatinib mesylate in steroid-refractory sclerodermatous chronic GVHD.甲磺酸伊马替尼在激素难治性硬皮病样慢性移植物抗宿主病中的疗效和耐受性有限。
Blood. 2012 Dec 13;120(25):5089-90. doi: 10.1182/blood-2012-09-453928.
3
More than skin deep? Emerging therapies for chronic cutaneous GVHD.
不止于皮肤？慢性皮肤移植物抗宿主病的新兴疗法。
Bone Marrow Transplant. 2013 Mar;48(3):323-37. doi: 10.1038/bmt.2012.96. Epub 2012 Aug 6.
4
Possible involvement of cytokines, chemokines and chemokine receptors in the initiation and progression of chronic GVHD.细胞因子、趋化因子及其受体在慢性移植物抗宿主病的发生和发展中的可能作用。
Bone Marrow Transplant. 2013 Jan;48(1):115-23. doi: 10.1038/bmt.2012.100. Epub 2012 Jun 4.
5
Lidocaine for systemic sclerosis: a double-blind randomized clinical trial.系统性硬皮病的利多卡因治疗：一项双盲随机临床试验。
Orphanet J Rare Dis. 2011 Feb 7;6:5. doi: 10.1186/1750-1172-6-5.
6
Treatment change as a predictor of outcome among patients with classic chronic graft-versus-host disease.治疗改变作为经典慢性移植物抗宿主病患者预后的预测指标。
Biol Blood Marrow Transplant. 2008 Dec;14(12):1380-4. doi: 10.1016/j.bbmt.2008.09.017.
7
Lidocaine down-regulates nuclear factor-kappaB signalling and inhibits cytokine production and T cell proliferation.利多卡因下调核因子-κB信号传导并抑制细胞因子产生及T细胞增殖。
Clin Exp Immunol. 2008 May;152(2):320-7. doi: 10.1111/j.1365-2249.2008.03636.x. Epub 2008 Mar 18.
8
Beneficial effect of intravenous lidocaine in cutaneous chronic graft-versus-host disease secondary to donor lymphocyte infusion.静脉注射利多卡因对供体淋巴细胞输注继发的皮肤慢性移植物抗宿主病的有益作用。
Bone Marrow Transplant. 2001 Jul;28(1):97-9. doi: 10.1038/sj.bmt.1703080.
9
Local anesthetic lidocaine inhibits the effect of granulocyte colony-stimulating factor on human neutrophil functions.局部麻醉药利多卡因可抑制粒细胞集落刺激因子对人中性粒细胞功能的影响。
Exp Hematol. 1994 May;22(5):460-6.
10
[Some little-known conservative methods of treatment of Raynaud's syndrome].[雷诺氏综合征一些鲜为人知的保守治疗方法]
Phlebologie. 1977 Apr-Jun;30(2):199-204.